31 results about "Clinical laboratory test" patented technology

The present invention relates to a clinical laboratory test apparatus capable of simply and quickly attaching and detaching a microchip. The clinical laboratory testing apparatus comprises a microchip having a measuring cell that holds a sample liquid; a rotation body; a rotation drive mechanism that rotates the rotation body; a lock mechanism that locks the microchip on the rotation body; a measurement room that holds the microchip and the rotation body and that has an attachment and detachment opening; a protection cover that closes the attachment and detachment opening; a light source that irradiates the measuring cell; and a light receiving unit that receives the light, wherein a centrifugal separation processing of a specimen in the sample liquid is performed in the microchip by the rotation drive mechanism rotating the rotation body, and wherein the protection cover has a pressing-down member that presses down a wall face of the microchip when the protection cover is closing the attachment and detachment opening.

This invention relates to the use of thermodynamically incompatible surfaces in agglutination assays for the express purpose of using the sample as a key component of the detection instrument. Specifically, the invention relates to formation of a lense and a virtual container for rapid mixing via thermal energy by a sample liquid disposed on a superhydrophobic surfaces, and a subsequent specific analyte or overall protein concentration assay using particles agglutination for use in the industrial, environmental, and clinical laboratory test fields.

A clinical laboratory test information system comprises: a memory configured to store time information regarding a plurality of stages included in a clinical-laboratory-test-relating operation; an operating device; a display unit; and a controller configured to: cause the display unit to display, based on the time information stored in the memory, first information indicating a temporal transition of a required time for each of the plurality of stages, such that each stage is selectable; and if one of the plurality of stages is selected by the operating device indicated in the first information, cause the display unit to display second information indicating a temporal transition of the required time for the selected stage.

This invention relates to the use of thermodynamically incompatible surfaces in agglutination assays for the express purpose of using the sample as a key component of the detection instrument. Specifically, the invention relates to formation of a lense and a virtual container for rapid mixing via thermal energy by a sample liquid disposed on a superhydrophobic surfaces, and a subsequent specific analyte or overall protein concentration assay using particles agglutination for use in the industrial, environmental, and clinical laboratory test fields.

Reference intervals are established and / or validated based on existing clinical data and exclusion criteria, such as diagnosis coding. A Reference Interval Test Engine is designed to statistically analyze large volumes of existing clinical lab test results to establish and evaluate reference intervals for specific population subgroups and / or to provide other applications.

Methods, devices and structures for the collection and transport of biological samples for use in clinical laboratory testing and / or evaluation are disclosed. In particular, the invention relates to the self-collection of such samples by the subject providing the samples. Self-collection is necessary in some situations, such as the subject's religious beliefs prohibiting the subject from being contacted by people other than family members and the subject being far from the medical facility.

The invention discloses an intelligent control system for text quality of a medical clinical laboratory. According to quality control data parameters set by the clinical laboratory, the intelligent control system can automatically receive quality control data sent by an automatic analytical instrument of the laboratory, send the quality control data to a professional third-party clinical laboratory test quality comparison system in real time to perform comparison and return comparison results to a laboratory information management system in real time. The invention further discloses an intelligent control method for the test quality of the medical clinical laboratory. By the intelligent control method, real-time data interaction between the laboratory information management system and the third-party clinical laboratory test quality comparison system can be realized without manual intervention, and accordingly, accuracy and reliability of clinical text results are guaranteed.

A clinical laboratory test apparatus of a health care information system includes a reading section that reads an optically readable code array, an extraction section that extracts, from a plurality of the code arrays read by the reading section, a rule that is common between the plurality of code arrays, a storage section that stores the rule extracted by the extraction section, and a determination section that determines authenticity of each of the code arrays read by the reading section based on the rule stored in the storage section. In testing a sample, in a case where it is determined by the determination section that the code array read by the reading section is true, the test is executed, and in a case where it is determined that the code array is false, the execution of the test is suspended.

The present invention recognizes that current clinical laboratory testing methods for multiparametric single cell analysis are limited to analysis of intact live cells, and are insufficient for identification of signaling activation profile defining certain cell types, including but not limited to neoplastic and immunologically activated cell subsets. One aspect of the present invention generally relates to marker selection in panels to include proteins routinely assessed in standard FCM, while preferably also incorporating markers for surface receptor proteins within activated signaling cascades. A further aspect of the present invention generally relates to panel design for the following indications in neoplastic and non-neoplastic clinical applications as examples of the technology: (a) identification of CML progenitor cell subsets in the setting of disease recurrence after treatment discontinuation or relapse due to treatment resistance, and (b) characterization of activated basophils to predict the severity of an allergic response. Another aspect of the present invention generally relates to methods to measure levels of surface and IC biomarkers in separate or combined assays for robust characterization of each or select cell compartment, and data analysis based on results from each or all method(s) used for optimal detection of the markers. A further aspect of the present invention generally relates to the identification and profiling of cell subpopulations based on analysis of surface markers including those associated with lineage and maturation of cell types and receptor proteins, and the corresponding IC phosphoproteins including those in activated signaling cascades to predict certain disease states or response to treatment.

The invention discloses a disinfectant special for an inspection instrument in the inspection department and a preparation method of the disinfectant. The disinfectant is prepared mainly by the following steps of crushing pawpaw, fructus aurantii immaturus, schisandra chinensis, pericarpium citri reticulatae, smoked plum, chinese holly, pomegranate bark, exocarpium, eucalyptus robusta smith, dogwood, folium eriobotryae, selfheal, myrobalan, corn silk, ligusticum wallichii, glossy privet fruits and pericarpium citri reticulatae viride, soaking, heating and reflowing, wherein an auxiliary material is a filter liquor which is prepared by heating poinsettia, radix angelicae, hemp fimble stem-fibre, subprostrate sophora and fungus-infected rice spike with ethanol and extracting, wherein an additive of polyhexamethylene guanidine is added. The disinfectant is faintly acid, and the environmental acidity can be changed, so that most bacteria which grow best within a PH range of 6.0 to 8.0, have the strongest enzymatic activity and strongly grow and breed cannot exist, and the bacterial growth is effectively inhibited; the disinfectant is easily dissolved in water, and the disinfectant is easily washed out without residues after being used; the disinfectant has the advantages of being small in corrosivity, good in stability and simple in preparation process, can be widely applied to disinfecting the inspection instrument in the inspection department and is suitable for mass production.